Pulmonary Fibrosis — Trials, FDA Actions & Pivotal Research

20 active Pulmonary Fibrosis trials currently recruiting in the US, sourced from ClinicalTrials.gov.

Synced daily from openFDA and ClinicalTrials.gov. Last sync: July 6, 2026.

Recruiting trials by city

Cities where Pulmonary Fibrosis trials in our archive had recruiting sites. Each link lists every currently recruiting paid clinical trial at that location.

Boston, MA Chicago, IL Los Angeles, CA Birmingham, AL Denver, CO San Francisco, CA

Active Pulmonary Fibrosis trials

Currently recruiting US trials matching Pulmonary Fibrosis, sourced live from ClinicalTrials.gov. We’ll add per-event articles here as those trials post results or hit primary completion.

Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis

for Pulmonary Fibrosis

3 locations incl. Birmingham

Sponsor: Bristol-Myers Squibb

Sex: All·Age: All ages

Code: NCT07441408·Phase 3·Not Yet Recruiting

This is a Trial Designed to Evaluate the Combination of Nerandomilast With Mycophenolate Across a Wide Variety of Pulmonary Fibrosis Subtypes, With the Aim of Providing Clinicians With Assurance That This is an Appropriate Therapeutic Combination.

for Pulmonary Fibrosis

Sponsor: University of British Columbia

Sex: All·Age: 18+

Code: NCT07570888·Phase 4·Not Yet Recruiting

Safety of Bronchoscopy in Patients With Interstitial Lung Disease

for Interstitial Lung Disease (ILD)

Sponsor: University of Milan

Sex: All·Age: 18+

Code: NCT07627594·Not Yet Recruiting

A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of RC010 Inhalation Powder in Healthy Participants

for IPF

Sponsor: Nanjing Reju Therapeutics Co., Ltd

Sex: All·Age: 18 - 55·Accepts healthy volunteers

Code: NCT07528703·Phase 1·Not Yet Recruiting

Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis

for Interstitial Lung Disease

1 location in Boston

Sponsor: Peter Caravan

Sex: All·Age: 18 - 80

Code: NCT07572383·Phase 2·Recruiting

Apply to this trial

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of HSK44459 Tablets in Patients With Idiopathic Pulmonary Fibrosis

for IPF

Sponsor: Haisco Pharmaceutical Group Co., Ltd.

Sex: All·Age: 40+

Code: NCT07519070·Phase 3·Not Yet Recruiting

Study on the Drug Interactions of HRS-9813, Pirfenidone and Nintedanib in Healthy Subjects

for Pulmonary Fibrosis

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd

Sex: All·Age: 18 - 45·Accepts healthy volunteers

Code: NCT07229716·Phase 1·Recruiting

Apply to this trial

A PhaseⅠ Study of HW252001 in Healthy Subjects

for IPF

Sponsor: Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.

Sex: All·Age: 18 - 55·Accepts healthy volunteers

Code: NCT07493031·Phase 1·Not Yet Recruiting

Clinical Application of 68Ga-1A12 PET in Fibrosis-related Diseases

for Pulmonary Fibrosis

Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Sex: All·Age: 18+

Code: NCT07459205·Not Yet Recruiting

Telomeres Length in Israeli Fibrotic ILD Patients

for Pulmonary Fibrosis

Sponsor: Barzilai Medical Center

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT06885515·Enrolling By Invitation

Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases

for Tumor

Sponsor: Peking Union Medical College Hospital

Sex: All·Age: 18 - 85·Accepts healthy volunteers

Code: NCT07464132·Phase 1, Phase 2·Recruiting

Apply to this trial

A Phase Ia Clinical Trial of HW241045

for Healthy Volunteers

Sponsor: Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.

Sex: All·Age: 18 - 55·Accepts healthy volunteers

Code: NCT07448194·Phase 1·Recruiting

Apply to this trial

SB17170 Phase 2 Trial in IPF Patients

for IPF

Sponsor: SPARK Biopharma

Sex: All·Age: 40+

Code: NCT06747923·Phase 2·Recruiting

Apply to this trial

Advanced Imaging for Pulmonary Fibrosis

for Pulmonary Fibrosis

1 location in Boston

Sponsor: Peter Caravan

Sex: All·Age: 18 - 80

Code: NCT06532071·Phase 2·Recruiting

Apply to this trial

Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis

for Pulmonary Fibrosis

1 location in Los Angeles

Sponsor: University of California, Los Angeles

Sex: All·Age: 18+

Code: NCT06162884·Recruiting

Apply to this trial

Routine vs On-demand ECMO for Lung Transplantation

for Respiratory Failure

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All·Age: 18+

Code: NCT06615492·Recruiting

Apply to this trial

P4O2 ILD Extension

for Interstitial Lung Disease

Sponsor: Amsterdam UMC, location VUmc

Sex: All·Age: 18 - 80

Code: NCT06644144·Recruiting

Apply to this trial

Implementation of Home Monitoring in Patients With Pulmonary Fibrosis

for Pulmonary Fibrosis

Sponsor: Erasmus Medical Center

Sex: All·Age: 18+

Code: NCT06883448·Recruiting

Apply to this trial

Physical Exercise Program for Adults With Diffuse Interstitial Lung Disease in a Pulmonary Rehabilitation Context

for Interstitial Lung Disease Due to Systemic Disease (Disorder)

Sponsor: Universidad de La Frontera

Sex: All·Age: 18+

Code: NCT07061873·Enrolling By Invitation

Pinpointing the Factors Affecting Clinical Study Experiences of Pulmonary Fibrosis Patients

for Pulmonary Fibrosis

1 location in San Francisco

Sponsor: Power Life Sciences Inc.

Sex: All·Age: 18+

Code: NCT05899556·Not Yet Recruiting